- Home
- TNYA vs JELD Comparison
TNYA vs JELD Comparison
Compare TNYA & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNYA | JELD |
|---|---|---|
| Founded | 2016 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.5M | 152.5M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | TNYA | JELD |
|---|---|---|
| Price | $0.78 | $1.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $5.33 | $3.43 |
| AVG Volume (30 Days) | ★ 2.4M | 1.5M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.96 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,211,181,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.53 | $0.93 |
| 52 Week High | $2.35 | $6.98 |
Technical Indicators
Market Signals| Indicator | TNYA | JELD |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 33.02 |
| Support Level | $0.65 | $0.93 |
| Resistance Level | $0.80 | $2.06 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 13.25 | 6.25 |
Price Performance
Historical ComparisonAbout TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.